BoB@JPM: Support Of A Blossoming Pipeline With Sangamo's Sandy Macrae, Ph.D.
Business Of Biotech
00:00
What's the Backstory on That Broad and Aggressive Preclinical Pipeline?
Sandy McCray has been CEO of Sangamos for six years. He says he can't imagine someone coming in for him, any of the position that would take me away from it. The company's pipeline includes everything from malaria to ED as an example. It's very rare for a company our size to have choices to make and there are many more things we could do but haven't because they're too expensive.
Transcript
Play full episode
